Can peptide receptor radionuclide therapy be safely applied in florid bone metastases of gastroenteropancreatic neuroendocrine tumours?

被引：0

作者：

Sabet, Amir ^{[1
]}

Yong-Hing, Charlotte ^{[2
]}

Ezziddin, Khaled ^{[1
]}

Ahmadzadehfar, Hojjat ^{[1
]}

Guhlke, Stefan ^{[1
]}

Gruenwald, Frank ^{[3
]}

Biersack, Hans Juergen ^{[1
]}

Ezziddin, Samer ^{[1
]}

机构：

[1] Dept Nucl Med, Bonn, Germany

[2] Univ British Columbia, Vancouver, BC, Canada

[3] Univ Hosp, Frankfurt, Germany

来源：

JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

1183

引用

页数：2

共 50 条

[31] Peptide receptor radionuclide therapy in non-neuroendocrine tumours - a field report [J].

Nilica, B. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 :S223-S223

[32] Angiogenic biomarkers of response to treatment with peptide receptor radionuclide therapy in neuroendocrine tumours [J].

Strzelczyk, Janusz ;

Wojcik-Giertuga, Monika ;

Makulik, Karolina ;

Rosiek, Violetta ;

Kaminski, Grzegorz ;

Kajdaniuk, Dariusz ;

Kos-Kudla, Beata .

ENDOKRYNOLOGIA POLSKA, 2024, 75 (04) :412-418

[33] Surgery enhances the effectiveness of peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumors Discussion [J].

Demeure, Michael ;

Tobias, Joseph ;

Dickson, Paxton ;

Howe, Jim ;

Beck, Timothy .

SURGERY, 2025, 177

[34] Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review [J].

Camus, Baptiste ;

Cottereau, Anne-Segolene ;

Palmieri, Lola-Jade ;

Dermine, Solene ;

Tenenbaum, Florence ;

Brezault, Catherine ;

Coriat, Romain .

JOURNAL OF CLINICAL MEDICINE, 2021, 10 (06) :1-18

[35] The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future [J].

Liberini, Virginia ;

Huellner, Martin W. ;

Grimaldi, Serena ;

Finessi, Monica ;

Thuillier, Philippe ;

Muni, Alfredo ;

Pellerito, Riccardo E. ;

Papotti, Mauro G. ;

Piovesan, Alessandro ;

Arvat, Emanuela ;

Deandreis, Desiree .

DIAGNOSTICS, 2020, 10 (12)

[36] The Use of Peptide Receptor Radionuclide Therapy in Patients With Neuroendocrine Tumor Cardiac Metastases [J].

Yu, Irene S. ;

Funk, Gayle ;

Lin, Eugene ;

Kennecke, Hagen F. .

CLINICAL NUCLEAR MEDICINE, 2021, 46 (01) :e23-e26

[37] Intra-Arterial Peptide Receptor Radionuclide Therapy Using Y-90 DOTATOC for Hepatic Metastases of Gastroenteropancreatic Neuroendocrine Tumors [J].

Heath, Courtney Lawhn ;

Fidelman, Nicholas ;

Bergsland, Emily ;

Hope, Thomas .

PANCREAS, 2020, 49 (03) :474-475

[38] Targeted Alpha Particle Therapy for Neuroendocrine Tumours: The Next Generation of Peptide Receptor Radionuclide Therapy [J].

Navalkissoor, Shaunak ;

Grossman, Ashley .

NEUROENDOCRINOLOGY, 2019, 108 (03) :256-264

[39] Lutetium-177 Dotatate peptide receptor radionuclide therapy outcomes for neuroendocrine tumours [J].

AlHilali, M. ;

Carberry, J. ;

Challis, A. ;

Atherton, P. .

RADIOTHERAPY AND ONCOLOGY, 2023, 182 :S1095-S1096

[40] Peptide Receptor Radionuclide Therapy In Broncopulmonary Neuroendocrine Tumours - Results Of A Single Centre Experience [J].

Ferreira, G. ;

Castro, S. ;

Costa, C. ;

Violante, L. ;

Teixeira, J. ;

Duarte, H. ;

Sampaio, I. L. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) :S89-S89

← 1 2 3 4 5 →